Pathogenesis of Hematologic Malignancies

Official record

Identifier

NCT01728402

Recruiting locations

country

United States

Interventions studied

blood draw, bone marrow procedure, or tissue biopsy

Lead sponsor

OHSU Knight Cancer Institute

Target enrolment

5000 participants

Study type

OBSERVATIONAL

Phase

Not provided in the official record

Status

Enrolling by invitation

First posted

Nov 19, 2012

Last updated on the registry

Aug 13, 2026

Age

1 Year

Sex

ALL

Study contact

No public contact is listed on the official record.

Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

* Suspected or confirmed diagnosis of AL, LPD, MDS, or MPD
* Male or female of all ages
* Willing and able to sign informed consent
* Willing guardian consent for participants under 18 years of age

Exclusion Criteria:

* No suspected or confirmed diagnosis of acute leukemias (AL), lymphoproliferative disorders (LPD), myelodysplastic syndromes (MDS), or myeloproliferative diseases (MPD)

Indexed under

Leukemia